TCM Group Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de TCM Group de 33.1% y 5.4% por año respectivamente. Se prevé que el BPA crezca en un 34% al año. Se espera que la rentabilidad financiera sea de 12.8% en 3 años.

Información clave

33.1%

Tasa de crecimiento de los beneficios

34.0%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Consumer Durables	25.9%
Tasa de crecimiento de los ingresos	5.4%
Rentabilidad financiera futura	12.8%
Cobertura de analistas	Low
Última actualización	25 Nov 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Is TCM Group A/S'(CPH:TCM) Recent Stock Performance Tethered To Its Strong Fundamentals?

Jan 25

Is TCM Group A/S (CPH:TCM) Trading At A 39% Discount?

Jan 11

The Trends At TCM Group (CPH:TCM) That You Should Know About

Dec 29

Previsiones de crecimiento de beneficios e ingresos

CPSE:TCM - Estimaciones futuras de los analistas y datos financieros pasados (DKK Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	1,380	87	88	122	2
12/31/2025	1,265	62	70	103	2
12/31/2024	1,191	50	36	69	1
9/30/2024	1,236	40	97	139	N/A
6/30/2024	1,217	30	109	153	N/A
3/31/2024	1,140	23	86	130	N/A
12/31/2023	1,111	22	38	81	N/A
9/30/2023	1,053	28	32	75	N/A
6/30/2023	1,059	39	8	47	N/A
3/31/2023	1,128	59	36	68	N/A
12/31/2022	1,146	70	39	72	N/A
9/30/2022	1,145	75	16	45	N/A
6/30/2022	1,143	103	9	43	N/A
3/31/2022	1,109	103	35	68	N/A
12/31/2021	1,108	111	40	74	N/A
9/30/2021	1,097	120	41	82	N/A
6/30/2021	1,082	106	80	115	N/A
3/31/2021	1,051	104	96	131	N/A
12/31/2020	1,025	102	101	132	N/A
9/30/2020	1,023	107	116	135	N/A
6/30/2020	1,014	109	130	148	N/A
3/31/2020	1,011	111	108	123	N/A
12/31/2019	1,007	111	131	146	N/A
9/30/2019	997	115	140	155	N/A
6/30/2019	962	112	136	149	N/A
3/31/2019	936	109	118	130	N/A
12/31/2018	900	104	125	134	N/A
9/30/2018	863	82	103	110	N/A
6/30/2018	846	63	N/A	103	N/A
3/31/2018	825	51	N/A	99	N/A
12/31/2017	817	48	N/A	107	N/A
9/30/2017	726	51	N/A	115	N/A
12/31/2016	469	26	N/A	78	N/A
12/31/2015	536	48	N/A	90	N/A
12/31/2014	437	24	N/A	56	N/A
12/31/2013	399	17	N/A	33	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (33.1% al año) de TCM es superior a la tasa de ahorro (1.2%).

Beneficios vs. Mercado: Se prevé que los beneficios (33.1% al año) de TCM crezcan más rápidamente que el mercado Danish (11.9% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de TCM crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (5.4% al año) de TCM crezcan más despacio que el mercado de Danish (10.1% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 5.4% al año) de TCM crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de TCM sea baja dentro de 3 años (12.8%).

TCM Group Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

TCM Group A/S Revises Earnings Guidance for the Year 2024

Price target increased by 21% to kr.82.50

Consensus EPS estimates increase by 41%

TCM Group A/S Revises Earnings Guidance for the Year 2024

TCM Group A/S Reiterates Earnings Guidance for Full Year 2024

TCM Group A/S Provides Earnings Guidance for Full Year 2024

Recent updates

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

TCM Group A/S Revises Earnings Guidance for the Year 2024

New minor risk - Market cap size

Price target increased by 21% to kr.82.50

Consensus EPS estimates increase by 41%

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

TCM Group A/S Revises Earnings Guidance for the Year 2024

TCM Group A/S Reiterates Earnings Guidance for Full Year 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

TCM Group A/S Provides Earnings Guidance for Full Year 2024

TCM Group A/S Elects Björn Olsson Lissner to the Board of Directors

TCM Group A/S Announces That Sanna Suvanto-Harsaae Does Not Seek Re-Election as Chairman and Member of Board of Directors

Consensus EPS estimates increase by 42%

Full year 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Share price stability

Now 24% undervalued

Investor sentiment improves as stock rises 17%

TCM Group A/S, Annual General Meeting, Apr 09, 2025

Third quarter 2023 earnings released: kr.0.16 loss per share (vs kr.1.07 profit in 3Q 2022)

TCM Group A/S Reaffirms Earnings Guidance for the Year 2023

Consensus EPS estimates fall by 63%

Price target decreased by 25% to kr.60.00

TCM Group A/S Provides Earnings Guidance for the Year 2023

Consensus EPS estimates fall by 15%, revenue upgraded

TCM Group A/S Revises Earnings Guidance for the Year 2023

Second quarter 2023 earnings released: EPS: kr.1.41 (vs kr.3.55 in 2Q 2022)

TCM Group A/S has completed a Follow-on Equity Offering in the amount of DKK 78.781526 million.

Price target decreased by 9.1% to kr.75.00

TCM Group A/S (CPSE:TCM) entered into an agreement to acquire Aubo Production A/S for DKK 225 million.

Tcm Group A/S Reiterates Full Year Revenue Guidance for the Financial Year 2023

First quarter 2023 earnings: EPS misses analyst expectations

Full year 2022 earnings: EPS misses analyst expectations

TCM Group A/S Announces CFO Changes

Price target decreased to kr.94.50

TCM Group A/S to Report Q4, 2023 Results on Feb 28, 2024

TCM Group A/S Announces Stepping Down of Mogens Elbrønd Pedersen as CFO

Chief Executive Officer Torben Paulin acquired unknown stake in TCM Group A/S (CPSE:TCM) for approximately DKK 0.1 million.

Some Investors May Be Willing To Look Past TCM Group's (CPH:TCM) Soft Earnings

Third quarter 2022 earnings released: EPS: kr.3.55 (vs kr.4.04 in 3Q 2021)

TCM Group A/S Provides Earnings Guidance for the Year 2022

Consensus EPS estimates fall by 29%

TCM Group A/S Revises Earnings Guidance for the Third Quarter and Full Year of 2022

TCM Group (CPH:TCM) Has A Somewhat Strained Balance Sheet

Second quarter 2022 earnings released: EPS: kr.3.55 (vs kr.3.28 in 2Q 2021)

TCM Group A/S Provides Revenue Guidance for Full Year 2022

Should You Think About Buying TCM Group A/S (CPH:TCM) Now?

Here's Why TCM Group (CPH:TCM) Has A Meaningful Debt Burden

Investor sentiment deteriorated over the past week

First quarter 2022 earnings: Revenues miss analyst expectations

TCM Group A/S Reiterates Revenue Guidance for Full Year 2022

Insufficient new directors

Price target decreased to kr.154

Investor sentiment deteriorated over the past week

TCM Group A/S Approves Dividend for the Year 2022

Upcoming dividend of kr.6.00 per share

Price target decreased to kr.154

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

What Does TCM Group A/S's (CPH:TCM) Share Price Indicate?

Consensus EPS estimates fall by 18%

TCM Group A/S Provides Earnings Guidance for the Full Year 2022

TCM Group A/S Provides Earnings Guidance for the Full Year 2022

Returns On Capital Are A Standout For TCM Group (CPH:TCM)

Third quarter 2021 earnings released: EPS kr.4.04 (vs kr.2.44 in 3Q 2020)

Second quarter 2021 earnings released: EPS kr.3.28 (vs kr.3.01 in 2Q 2020)

TCM Group A/S Provides Earnings Guidance for the Second Quarter Ended June 30, 2021 and Revises Earnings Guidance for the Full Year of 2021

Capital Investment Trends At TCM Group (CPH:TCM) Look Strong

First quarter 2021 earnings released: EPS kr.2.47 (vs kr.2.26 in 1Q 2020)

TCM Group A/S Reiterates Earnings Guidance for the Full Year of 2021

Is Now An Opportune Moment To Examine TCM Group A/S (CPH:TCM)?